Shares of ProQR Therapeutics N.V. (PRQR) have gained 22 percent over the last 10 trading days as the Company gears up to report findings from a planned three-month interim analysis of its trial, dubbed STELLAR, on March 31, 2020.
from RTT - Biotech https://ift.tt/3dIwp9A
via IFTTT
No comments:
Post a Comment